Natural Cancer Therapies

IV Vitamin C Therapy for Cancer


An Effective Therapy for Cancer

Intravenous Vitamin C is an effective and natural adjunctive cancer therapy that not only has cyto-toxic effects to tumor cells, but has also been shown to increase the effectiveness of conventional chemotherapeutic drugs. Several leading oncology units in North America now use intravenous Vitamin C as a treatment option; not surprisingly, as it has the following benefits:

  • Prolongs survival
  • Increases quality of life
  • Reduces cancer cell survival and does not affect normal cell lines
  • Works synergistically with conventional chemotherapy and radiation and reduces the side-effects of those treatments
  • Inhibits hyaluronidase, an enzyme produced by cancer cells that allows them to spread throughout the body (metastasize). By inhibiting this enzyme, the healthy tissue surrounding tumor cells remains intact and cancer is inhibited from spreading
  • Increases intracellular hydrogen peroxide which is directly cytotoxic to cancer cells
  • I.V. route of administration achieves plasma levels of Vitamin C consistent with concentrations demonstrated in vitro to be cytotoxic to several cancer cell lines
  • I.V. Vitamin C corrects an ascorbate deficiency, often seen in cancer patients
  • I.V. Vitamin C helps prevent systemic free radical injury

I.V. Vitamin C takes 1-1/2 hours to administer and the only side-effect that any of my patients have experienced is a need to urinate during or immediately following the treatment. The treatment is extremely safe and one of the strongest natural therapies for treatment of all types of cancer.

A recent systematic review examined evidence from randomized controlled trials of supplemental antioxidant nutrients administered concurrently with conventional cancer treatments (Block 2007). No evidence was found that supported concerns that antioxidant supplementation given concurrently with ROS-generating chemotherapy diminished the efficacy of the chemotherapy.

A separate review included over 280 peer-reviewed papers collectively over 8,500 subjects. Again, a comprehensive review of the area highlights a lack of adverse interaction from combined antioxidant and chemotherapy intervention. Studies,  including almost 4,000 patients actively receiving antioxidant therapy, find increased survival as a treatment outcome (Simone 2007). One paper presented, (Padayatty 2006), published in the Canadian Medical Association Journal, highlights what is likely to become the future of intravenous Vitamin C therapy in cancer. The paper includes contributions from the National Cancer Institute, the National Institute of Health, Centers for Cancer Research, and McGill University. Since the publication of this paper, several leading cancer clinics across North America have begun adding intravenous vitamin C to various regimes. The ability of vitamin C to prolong survival, improve quality of life, and reduce adverse effects of conventional cancer therapies has been reproducibly demonstrated over several decades. Recent research efforts of leading cancer clinics strongly supports previous reports of profound positive impact from the intervention.

Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev. 2007; 33(5):407-18.

Cameron E and Pauling L: Cancer and Vitamin C. Philadelphia. Camino Books. 1993.

Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered vitamin C as cancer therapy: three cases.

CMAJ. 2006;174(7):937-42. Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med. 2007 Mar-Apr;13(2):40-7.

Alpha lipoic acid (ALA) is one of the most powerful naturally occurring anti-oxidants, like vitamin C and E, and helps protect cells from damage. Because it is both water and fat soluble, and able to provide a much wider range of anti-oxidant protection throughout the body in various environments, it is commonly referred to as an ‘universal’ anti-oxidant. In other words, it can enter nerve cells and cross the blood-brain barrier to address neurological issues.

Lipoic acid is further believed to strengthen the effects of other antioxidants (such as Vitamins C and E) and to regenerate antioxidants (such as Vitamin C, Coenzyme Q10 and Glutathione) used up in the fight against free radicals. Lastly, it plays a critical role in cellular energy production which fuels other activities in the body.

IV alpha lipoic acid (ALA) is used to treat cancer (especially pancreatic cancer with metastasis), neuropathy, diabetes (including conditions related to poorly managed diabetes, such as: peripheral neuropathy, retinopathy, cardiovascular disease, kidney disease, and erectile dysfunction), as well as successfully prevent and treat chronic liver disease. ALA can play a noteworthy role as a complementary therapy to reduce the side effects of radiation therapy or chemotherapy.

Mistletoe Cancer Therapy

Mistletoe Therapy (Helixor, Iscador) is an adjunctive cancer treatment for patients with all types of cancer or precancerous conditions. Its use began in the 1920’s with Rudolf Steiner, PhD, founder of the Society for Cancer Research in Arlesheim, Switzerland. European Mistletoe (Viscum album) is given as subcutaneous injections in a homeopathic form. It has been approved for use in West Germany, Switzerland and Austria and is also used in France, Britain, Holland and Scandinavia. Naturopathic Physicians feel that it is the combined effect of all components of this plant that make it a potent anti-cancer medicine and that isolation of components can only begin to explain the entire beneficial effect of a plant medicine.

Studies have shown that Mistletoe injections have the following effects:

  • Inhibition of metastasis, tumor size reduction and necrosis of induced tumors in rodents
  • Improved survival with patients suffering from breast and colorectal cancer
  • Improved quality of life in patients with cancer tumors including improved mood, endurance, appetite, tolerance of chemotherapy, sleep and decreased fatigue and pain
  • Mistletoe lectins have been shown to induce apoptosis (cancer cell death). Studies indicate that mistletoe lectins may specifically target some forms of cancer and leave “normal” cells alone. This may be an advantage over chemotherapy which targets any cell, healthy or cancerous, which turns over rapidly
  • Enhancement of immune system including activation of T-helper cells, natural killer cells and other components of the immune system which may target and destroy cancerous cells
  • Stabilizing effect on DNA, preventing further mutation into cancer cells
  • Alleviation of some side-effects of chemotherapy and radiation

The National Institutes of Health is currently running a research study to find out whether an extract from the European mistletoe plant, along with a chemotherapy drug called gemcitabine, can help treat people with certain cancers.

Safety of Mistletoe injections:

Collection and evaluation of spontaneously reported side effects in over 300,000 patients over 28 years have shown the relative frequency of side effects to be 0.004%. In 66% of patients there was a harmless local reaction or fever and all side effects were completely reversible with no death and no damage to organs.

White Rock Naturopathic Clinic and Dr Grodski are proud to provide a broad array of cancer care therapies and treatments, including IV Vitamin C and Mistletoe Cancer Therapy to those in need in the Lower Mainland.